Page 175 - IJB-10-6

International Journal of Bioprinting 3D bioprinting technology for brain tumor

2. Yi HG, Jeong YH, Kim Y, et al. A bioprinted human- 14. Van Norman GA. Limitations of animal studies for
glioblastoma-on-a-chip for the identification of patient- predicting toxicity in clinical trials: is it time to rethink our
specific responses to chemoradiotherapy. Nat Biomed Eng. current approach? JACC Basic Transl Sci. 2019;4(7):845-854.
2019;3(7):509-519. doi: 10.1016/j.jacbts.2020.03.010
doi: 10.1038/s41551-019-0363-x
15. Kang Y, Datta P, Shanmughapriya S, Ozbolat IT. 3D
3. Wang YI, Abaci HE, Shuler ML. Microfluidic blood-brain bioprinting of tumor models for cancer research. ACS Appl
barrier model provides in vivo‐like barrier properties Bio Mater. 2020;3(9):5552-5573.
for drug permeability screening. Biotechnol Bioeng. doi: 10.1021/acsabm.0c00791
2017;114(1):184-194. 16. Gungor-Ozkerim PS, Inci I, Zhang YS, Khademhosseini
doi: 10.1002/bit.26045
A, Dokmeci MR. Bioinks for 3D bioprinting: an overview.
4. Tang M, Xie Q, Gimple RC, et al. Three-dimensional Biomater Sci. 2018;6(5):915-946.
bioprinted glioblastoma microenvironments model doi: 10.1039/c7bm00765e
cellular dependencies and immune interactions. Cell Res. 17. Prendergast ME, Burdick JA. Computational modeling and
2020;30(10):833-853. experimental characterization of extrusion printing into
doi: 10.1038/s41422-020-0338-1
suspension baths. Adv Healthc Mater. 2022;11(7):e2101679.
5. Silvani G, Basirun C, Wu H, et al. A 3D‐bioprinted doi: 10.1002/adhm.202101679
vascularized glioblastoma‐on‐a‐chip for studying the impact 18. Ozbek II, Saybasili H, Ulgen KO. Applications of 3D
of simulated microgravity as a novel pre‐clinical approach in bioprinting technology to brain cells and brain tumor
brain tumor therapy. Adv Ther. 2021;4(11):2100106. models: special emphasis to glioblastoma. ACS Biomater Sci
doi: 10.1002/adtp.202100106
Eng. 2024;10(5):2616-2635.
6. Colopi A, Fuda S, Santi S, et al. Impact of age and gender doi: 10.1021/acsbiomaterials.3c01569
on glioblastoma onset, progression, and management. Mech 19. Qiu B, Bessler N, Figler K, et al. Bioprinting neural systems
Ageing Dev. 2023;211:111801. to model central nervous system diseases. Adv Funct Mater.
doi: 10.1016/j.mad.2023.111801
2020;30(44):1910250.
7. Lauko A, Lo A, Ahluwalia MS, Lathia JD. Cancer cell doi: 10.1002/adfm.201910250
heterogeneity & plasticity in glioblastoma and brain tumors. 20. DePalma TJ, Sivakumar H, Skardal A. Strategies for
Semin Cancer Biol. 2022;82:162-175. developing complex multi-component in vitro tumor
doi: 10.1016/j.semcancer.2021.02.014
models: highlights in glioblastoma. Adv Drug Deliv Rev.
8. Schaff LR, Mellinghoff IK. Glioblastoma and other 2022;180:114067.
primary brain malignancies in adults: a review. JAMA. doi: 10.1016/j.addr.2021.114067
2023;329(7):574-587. 21. Jiao W, Shan J, Gong X, et al. GelMA hydrogel: a game-
doi: 10.1001/jama.2023.0023
changer in 3D tumor modeling. Mater Today Chem.
9. Xie Z, Chen M, Lian J, Wang H, Ma J. Glioblastoma-on-a- 2024;38:102111.
chip construction and therapeutic applications. Front Oncol. doi: 10.1002/adfm.201910250
2023;13:1183059. 22. Jung M, Ghamrawi S, Du EY, Gooding JJ, Kavallaris M.
doi: 10.3389/fonc.2023.1183059
Advances in 3D bioprinting for cancer biology and precision
10. Angom RS, Nakka NMR, Bhattacharya S. Advances in medicine: from matrix design to application. Adv Healthc
glioblastoma therapy: an update on current approaches. Mater. 2022;11(24):e2200690.
Brain Sci. 2023;13(11):1536. doi: 10.1002/adhm.202200690
doi: 10.3390/brainsci13111536
23. Crivii C-B, Boșca AB, Melincovici CS, et al. Glioblastoma
11. Sharma P, Aaroe A, Liang J, Puduvalli VK. Tumor microenvironment and cellular interactions. Cancers.
microenvironment in glioblastoma: current and emerging 2022;14(4):1092.
concepts. Neurooncol Adv. 2023;5(1):vdad009. doi: 10.1002/adfm.201910250
doi: 10.1093/noajnl/vdad009
24. Thenuwara G, Javed B, Singh B, Tian F. Biosensor-enhanced
12. Pineda E, Domenech M, Hernandez A, Comas S, Balana organ-on-a-chip models for investigating glioblastoma tumor
C. Recurrent glioblastoma: ongoing clinical challenges and microenvironment dynamics. Sensors. 2024;24(9):2865.
future prospects. Onco Targets Ther. 2023;16:71-86. doi: 10.3390/s24092865
doi: 10.2147/OTT.S366371
25. Parra-Cantu C, Li W, Quiñones-Hinojosa A, Zhang YS.
13. Knowlton S, Onal S, Yu CH, Zhao JJ, Tasoglu S. Bioprinting 3D bioprinting of glioblastoma model. J 3D Print Med.
for cancer research. Trends Biotechnol. 2015;33(9):504-513. 2020;4(2):113-125.
doi: 10.1016/j.tibtech.2015.06.007 doi: 10.2217/3dp-2019-0027

Volume 10 Issue 6 (2024) 167 doi: 10.36922/ijb.4166